Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study

BACKGROUND: Adherence to chronic obstructive pulmonary disease (COPD) maintenance medication is important for managing symptoms and exacerbation risk, and is associated with reduced mortality, hospitalizations, and costs. This study compared on-treatment exacerbations, medical costs, and medication...

Full description

Saved in:
Bibliographic Details
Published in:BMC Pulm Med
Main Authors: Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, Mahendran, Malena, Hahn, Beth
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325860/
https://ncbi.nlm.nih.gov/pubmed/34332555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01612-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items